**Core Concept**
Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are a class of antiretroviral drugs used to treat HIV infection. They work by binding to the reverse transcriptase enzyme, which is essential for the replication of retroviruses like HIV, thereby inhibiting viral replication.

**Why the Correct Answer is Right**
Ritonavir is actually a member of the protease inhibitor (PI) class of antiretroviral drugs, not an NNRTI. It works by inhibiting the protease enzyme, which is responsible for processing viral proteins, thereby preventing viral replication. Ritonavir is often used in combination with other medications to boost their effectiveness.

**Why Each Wrong Option is Incorrect**
**Option B:** Nevirapine is an NNRTI that works by binding to the reverse transcriptase enzyme, inhibiting viral replication. It's used in combination with other medications to treat HIV infection.
**Option C:** Efavirenz is also an NNRTI that binds to the reverse transcriptase enzyme, preventing viral replication. It's often used in combination with other medications to treat HIV infection.
**Option D:** Delavirdine is another NNRTI that works by binding to the reverse transcriptase enzyme, inhibiting viral replication. It's used in combination with other medications to treat HIV infection.

**Clinical Pearl / High-Yield Fact**
When prescribing antiretroviral therapy for HIV infection, it's essential to choose a regimen that includes a combination of medications from different classes to prevent the development of resistance.

**✓ Correct Answer: A. Ritonavir** Ritonavir is a protease inhibitor, not an NNRTI.